Home Commercial Gene Editing Firm, Graphite Bio, Takes +85,000 SQFT Lease at Nexus on Grand in South San Francisco
CommercialINDUSTRY newsNews Releases

Gene Editing Firm, Graphite Bio, Takes +85,000 SQFT Lease at Nexus on Grand in South San Francisco

Share
Share

Next-generation gene editing company to occupy three full floors of ground-up, Class A life sciences development in one of the top biotech markets in the U.S. SAN FRANCISCO – (January 26, 2022) – Savills announced that it completed an 85,165-square-foot lease relocation and expansion on behalf of Graphite Bio, Inc. (NASDAQ: GRPH) at 233 East Grand Avenue, a Class […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Partner Content

2026 Northern California CRE Rising Stars

NorCal rising stars 2026

Partner Content


Recent Posts

Related Articles